SOX17 directly activates
-SOX17 is a SRY-related high-mobility group (HMG) box transcription factor that is necessary for endoderm formation in multiple species. Despite its essential function during endoderm formation and differentiation, few direct targets of SOX17 are known. To identify targets of SOX17, we isolated SOX17 binding sites with a chromatin immunoprecipitation (ChIP)-cloning screen. SOX17-ChIP identified zinc finger protein 202 (Zfp202) as a direct target of SOX17 during endoderm differentiation of F9 embryonal carcinoma cells. A sequence in the first intron of Zfp202 activated transcription in differentiated F9 cells, and overexpression of Sox17 increased the transcriptional activity of this sequence. SOX17 binds to a site within this sequence in electrophoretic mobility shift assays, and mutation of this site decreases the transcriptional activation. Zfp202 is induced concomitantly with Sox17 during endoderm differentiation of F9 cells. We also show that ZFP202 represses Hnf4a, which has been reported for the human ortholog ZNF202. Identifying targets of SOX17 will help to elucidate the molecular basis of endoderm differentiation and may provide a better understanding of the role of endoderm in patterning the other germ layers.
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MEMBERS OF THE SOX FAMILY of transcription factors were originally defined by the presence of a single high-mobility group (HMG) box DNA binding domain with Ͼ50% homology to the SRY HMG box (8) . With the discovery of new SOX sequences (21, 25) , non-SRY SOX proteins can be best defined by conservation of a 9-amino acid sequence within the HMG box (3) . SOX proteins can be divided into 10 groups, although 3 groups contain a single member (3) . They are necessary for many developmental processes including gastrulation and organogenesis (13, 28, 32, 43) . Sox2 is required for epiblast and extraembryonic ectoderm formation in the mouse embryo (1) . Sry and Sox9 are required for testis formation (2, 17, 40) , and Sox18 has been shown to be necessary for cardiogenesis and angiogenesis (19, 31, 47) .
Sox17 has been found to be necessary for the formation of endoderm in several species including Mus musculus, Xenopus laevis, and Danio rerio (35) . In frogs, ectopic expression of Sox17 can direct expression of endodermal markers (11) . In addition, a fusion of the Sox17 HMG box to the Drosophila Engrailed repressor domain demonstrated the necessity of Sox17 for endoderm formation in frogs (11) . The requirement for Sox17 in endoderm formation was confirmed in another study using morpholinos (4) . In mice, targeted disruption of Sox17 results in embryonic lethality due to a lack of definitive endoderm formation (14) . Expression of Sox17 is limited to the primitive and definitive endoderm in early mouse embryos (14) . Sox17 expression is first detected in the extraembryonic endoderm at embryonic day (E)6 and in the anterior primitive streak, which gives rise to the definitive endoderm, by E7.
Despite the important and specific role of SOX17 in endoderm formation and differentiation, few direct targets are known. Previous studies have identified Lama1, Fn1, Foxj1, Sftpc, and Fgf3 as direct targets of SOX17 in the mouse (23, 24, 26, 34) . Other genes including Hnf1␤, Foxa1, Foxa2, Edd, and Sox17␣ have been identified as direct targets of Sox17␤ in X. laevis (10, 11, 36) , and uteroglobin (ug) has been identified as a SOX17 target in rabbit (7) . Identification of direct targets of SOX17 during mammalian endoderm differentiation is critical to understanding the molecular basis of endoderm differentiation.
Chromatin immunoprecipitation (ChIP) is a useful tool to identify transcription factor binding sites. It identifies in vivo binding of proteins to native chromatin structures and has been used to quantify this binding (45, 46) . By cloning DNA isolated after ChIP, novel target sequences of a transcription factor can be identified that can then be evaluated in downstream assays to assess their transcriptional activity. ChIPcloning strategies have been used successfully to identify direct target genes for E2F, BARX2, and RUNX1 (12, 37, 44) .
To better understand the function of SOX17 during endoderm differentiation in the mouse, we sought to identify targets of SOX17 by using a ChIP-cloning approach. The in vitro differentiation potential of F9 embryonal carcinoma cells has been well studied over the past 30 years, and simple protocols for visceral and parietal endoderm differentiation have been developed (9, 38) . We used the in vitro parietal endoderm differentiation of F9 cells, during which SOX17 expression is induced, to avoid using overexpression constructs that may isolate DNA that would not be bound by SOX17 in a normal physiological context.
Here we report the identification of 30 unique targets of SOX17 in differentiated F9 cells and present detailed characterization of one of these sequences. The majority of sequences isolated from SOX17-ChIP contain putative SOX17 binding sites, and genes associated with sequences that enhance transcription are induced during F9 differentiation. Finally, genes regulated by SOX17 that are induced during F9 differentiation are coexpressed with Sox17 in embryos.
MATERIALS AND METHODS
Cell culture. F9 and HepG2 cells were obtained from the American Type Culture Collection (ATCC) and grown in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) with 10% fetal bovine serum (FBS, Atlanta Biologicals) and 1% penicillin-streptomycin (Invitrogen). F9 cells were grown on gelatin-coated plates and differentiated by growing in medium consisting of DMEM ϩ 10% FBS supplemented with 100 nM all-trans retinoic acid (Sigma) and 1 mM dibutyryl cAMP (Sigma) for 4 days.
Immunocytochemistry. Cells were fixed in 4% paraformaldehyde-PBS for 5 min at room temperature and blocked in PBS containing 0.1% Triton X-100 and 10% donkey serum for 15 min at room temperature. Cells were incubated with primary antibodies diluted in PBS containing 0.1% Triton X-100 and 1% donkey serum for 1 h at room temperature. Goat anti-SOX17 (R&D Systems) was used at a 1:250 dilution, and donkey anti-goat IgG 488 (Molecular Probes) was diluted 1:1,000. Nuclei were stained with DAPI in PBS for 5 min at room temperature.
Immunoblots. Nuclear lysate was prepared with NE-PER (Pierce Biotechnology) per manufacturer's instructions. Ten micrograms of nuclear lysate was separated on a 7.5% SDS-PAGE gel (Bio-Rad) and electroblotted onto polyvinylidene difluoride (PVDF) membrane (Millipore). Membranes were blocked with 5% nonfat milk in Trisbuffered saline ϩ 0.1% Tween 20. The following antibodies were used: goat anti-SOX17 (1:1,000, R&D Systems), anti-SOX2 (1:1,000, Chemicon), rabbit anti-goat IgG HRP (1:10,000, Bethyl Labs), and sheep anti-rabbit IgG (1:200,000, GE Healthcare). ECL Plus (GE Healthcare) was used for detection per manufacturer's recommendations.
Chromatin immunoprecipitation. F9 cells differentiated for 4 days in the presence of retinoic acid and dibutyryl cAMP were fixed for 10 min by addition of formaldehyde directly to the medium to a final concentration of 1% and shaking (all steps were done at room temperature unless otherwise stated). Glycine was added to a final concentration of 125 mM, and shaking was continued for 5 min. Cells were washed with PBS, trypsinized for 5 min, and pelleted at 200 g. Cells were washed with PBS containing 1 mM PMSF and resuspended in cell lysis buffer (5 mM PIPES pH 8, 85 mM KCl, 0.5% NP-40) including protease inhibitors (1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin). Cells were incubated on ice for 10 min, and nuclei were pelleted at 4°C in a microcentrifuge for 5 min at 5,000 rpm. Nuclei were resuspended in nuclear lysis buffer (50 mM Tris-Cl pH 8.1, 10 mM EDTA, 1% SDS) plus protease inhibitors and incubated on ice for another 10 min. Chromatin was then sonicated with a Sonic Dismembranator 100 (Fisher Scientific) at a setting of 30% with four pulses of 15 s each. Chromatin was precleared with protein G agarose beads that were prepared by washing three times in dialysis buffer (50 mM Tris pH 8, 2 mM EDTA, 0.2% sarkosyl) and blocked with 1 g of Escherichia coli DNA and 1 g of BSA per 1 l of 25% bead slurry overnight at 4°C. Beads were added to sheared chromatin from 10 8 cells. An antibody to SOX17 was added, and tubes were rotated overnight at 4°C. Protein G agarose beads were added, and tubes were rotated for 4 h at 4°C. Beads were pelleted and washed once in wash I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8, 150 mM NaCl), wash II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8, 500 mM NaCl), and wash III (0.25 M LiCl, 1% Igepal, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris pH 8) and twice in Tris-EDTA pH 8. DNA was eluted twice in 150 l of elution buffer (100 mM NaHCO3, 1% SDS). Nineteen microliters of 5 M NaCl and 10 g of DNase-free RNase A were added to a final concentration of 300 mM, and samples were incubated at 67°C for 6 h. Proteinase K was added, and samples were incubated at 45°C for 1 h. Samples were then extracted with phenol-chloroform, and DNA was precipitated with ethanol at Ϫ20°C overnight. DNA was resuspended and incubated with T4 polymerase (NEB) for 30 min at 37°C to blunt DNA ends. To remove E. coli blocking DNA, samples were digested with DpnI (NEB), which selectively cuts E. coli DNA, for 60 min at 37°C and heat inactivated for 20 min at 80°C. DNA was then run over a SizeSep 400 column (GE Healthcare) to remove the digested E. coli DNA. Eluted DNA was extracted with phenol-chloroform and used for cloning.
Pilot experiments using herring sperm DNA revealed that blocking DNA was often cloned instead of actual SOX17 binding sites. To increase the percentage of mouse clones sequenced, we used E. coli DNA to block nonspecific DNA binding sites. After ChIP and DNA elution, DNA ends were blunted for cloning and the eluate was digested with DpnI. After cloning and transformation of DNA isolated from SOX17-ChIP, we picked bacterial clones for colony PCR. We then digested the PCR reactions with MboI to identify clones containing the sequence GATC to decrease sequencing of cloned E. coli DNA fragments. This strategy resulted in a 10-fold increase in the percentage of mouse clones sequenced.
Vector construction and cloning of ChIP DNA. pGL3-Basic (Promega) was digested with BglII (NEB) and ligated with annealed oligos (single-stranded portion underlined) 5Ј-GATCTTGGGCCCTAG-GAATTCAACTAGTGAAGGGGGGCTATAAAAGCGATGGATCC GAGCTCGGCCCTCATTCTGGAGACTCTAGAGGGATC-3Ј to create pGL3-MP containing a synthetic minimal promoter consisting of a TATA box and a transcription initiation start site for luciferase.
DNA fragments isolated by ChIP were ligated into EcoRV (NEB)-digested pZero2 (Invitrogen) with high-concentration T4 ligase (NEB) and transformed into TOP10 bacteria (Invitrogen). Colonies were analyzed by colony PCR, and selected colonies were sequenced. A subset of sequenced clones were digested and ligated in both orientations with NheI/XhoI or SpeI/XhoI into NheI/XhoI (NEB)-digested pGL3-MP for use in the luciferase assay. The P6G2 constructs contained the P6G2 clone inserted upstream of the minimal promoter in pGL3-MP in both the "ϩ" (P6G2ϩ) and "Ϫ" (P6G2Ϫ) orientations.
A portion of the Hnf4a promoter was amplified with primers 5Ј-GGCTCGAGATTAGCACCCCAGGTGTCAG-3Ј and 5Ј-GGAC-TAGTGTCCCTTCTCTGCCTTCCTC-3Ј and cloned into pGL3-Basic to create pGL3-Hnf4a.
Colony PCR. Platinum Taq (Invitrogen) was used according to manufacturer's recommendations with M13F and M13R primers. Thermal cycling conditions were [93°C for 5 min, 35 cycles of (93°C for 60 s, 55°C for 60 s, 72°C for 90 s), 72°C for 5 min]. PCR reactions were then split into two tubes, and one tube was digested with MboI (NEB) for 1 h to identify putative mouse clones.
PCR and RT-PCR. DNA from ChIP was used as a template for PCR. Platinum Taq (Invitrogen) was used as described by the manufacturer. Primers for the Lama1 enhancer were 5Ј-CCTCAGCTCCAAGAAAG-GAG-3Ј and 5Ј-AGGATGCTTCCCTGAAATCC-3Ј (214 bp); Cps1 promoter 5Ј-CATGTCCATTGGAACATCTCTGGAC-3Ј and 5Ј-TA-AAATTAAATCACAAATATCTCATGAG-3Ј (221 bp); and P6G2 5Ј-CTGCCTGATATTTGGTGCTG-3Ј, 5Ј-AATGGCTCTCATGGAAG-TGG-3Ј (183 bp).
Densitometric analysis was used to quantify fold enrichments of ChIP clones. ChIP clones were amplified from Sox17-ChIP or IgGChIP samples. PCR reactions were run on 1% agarose gels and stained with ethidium bromide. Gels were photographed, and band intensity was quantified with Quantity One software (Bio-Rad). Fold enrichment was expressed as background-subtracted band intensity for Sox17-ChIP/IgG-ChIP.
For RT-PCR, 2 g of total RNA was incubated with RNase-free DNase for 30 min at 37°C and then for 10 min at 75°C. Three hundred nanograms of oligo(dT) or random decamers (Ambion) was added and incubated at 65°C for 5 min. Tubes were incubated on ice and 500 M dNTPs, 40 U of RNase inhibitor, and 40 U of Moloney murine leukemia virus reverse transcriptase (MMLV-RT) (RTϩ) or H2O (RTϪ) were added. Reactions were incubated for 60 min at 42°C for cDNA synthesis. One hundred nanograms of cDNA was used per PCR reaction. Primers used for RT-PCR are available upon request. SOX17 in vitro transcription/translation and electrophoretic mobility shift assay. SOX17 protein was produced with the TNT T7 Coupled Wheat Germ Extract System (Promega) and XhoI (NEB)-digested pcDNA3.1 containing full-length Sox17 cDNA. Production of SOX17 protein was confirmed by Western blot. Reaction conditions for electrophoretic mobility shift assay (EMSA) were 1ϫ binding buffer (10 mM Tris pH 7.5, 50 mM KCl, 1 mM DTT), 50 ng/l poly(dG-dC) (GE Healthcare), 10% glycerol, 2 mM MgCl 2, 1 mM EDTA, 0.1% Triton X-100, and 1 l of TNT-SOX17. Reactions were incubated at room temperature for 5 min. Twenty femtomoles of biotinylated probe was added, and reactions were incubated for a further 30 min at room temperature. Reactions were separated on a 5% polyacrylamide-Tris-borate-EDTA gel (Bio-Rad) and electroblotted to Hybond Nϩ nylon membrane (GE Healthcare). A LightShift chemiluminescent EMSA kit was used for detection (Pierce Biotechnology).
Transfections and luciferase assays. Differentiated F9 cells were transiently cotransfected with pGL3-MP firefly luciferase constructs and phRL-SV40 (Promega), using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Cells were lysed at 24 h with Passive Lysis Buffer and assayed with the Dual Luciferase Kit (Promega). Each transfected well was read three times for firefly and Renilla luciferase activity, and each transfection was performed in triplicate. Each transfection was done on at least two different days to confirm results. Values were subjected to unpaired two-tailed t-tests.
pGL3-Hnf4a was transfected into HepG2 cells with Fugene6 (Roche Applied Science) and phRL-SV40. In certain experiments, a plasmid expressing Zfp202 (IMAGE Id 6334069) was cotransfected. Cells were lysed at 24 h and assayed with the Dual Luciferase Kit (Promega).
Site-directed mutagenesis. A QuikChange Site-Directed Mutagenesis Kit (Stratagene) was used to mutate SOX17 binding sites in the P6G2 constructs. Primers used for P6G2 mutagenesis were site A 5Ј-GTCCCCCAAGAGATTTCCTTCTCACCAAAGAATTTC-3Ј and 5Ј-GAAATTCTTTGGTGAGAAGGAAATCTCTTGGGGGAC-3Ј and site B 5Ј-GTTCTTAACCACTCAACCTTCTTCCAGTCCCCCAAG-3Ј and 5Ј-CTTGGGGGACTGGAAGAAGGTTGAGTGGTTAAGAAC-3Ј. Putative SOX17 binding sites are underlined, and the introduced mutations are in bold.
Whole mount in situ hybridization. In situ hybridizations were performed as previously described (29) . The probe for Sox17 has been previously described (15) . Collection of mouse embryos for in situ hybridization was performed under a protocol approved by the Johns Hopkins University Animal Care and Use Committee. Pregnant CD1 mice were killed by CO 2 inhalation. The probe sequence for Zfp202 was designed to the 3Ј-untranslated region (UTR) with the following primers: 5Ј-TTTTGACAGGCTGCTCCTTT-3Ј and 5Ј-AGGCAGG-GATACCAAGGACT-3Ј. The sequence was compared with the mouse expressed sequence tag (EST) database at NCBI and found to be specific to Zfp202. DIG-labeled probes were generated with the DIG RNA Labeling Kit (Roche Applied Science).
RESULTS

SOX17 is induced during endoderm differentiation of F9
cells. We prepared nuclear protein lysates from undifferentiated F9 cells and F9 cells differentiated to parietal endoderm to validate the F9 differentiation and investigate SOX17 protein abundance. Western blots (Fig. 1C) demonstrate an absence of SOX17 in undifferentiated F9 nuclear extract and a high level of SOX17 expression in differentiated F9 nuclear extract. Conversely, SOX2 is present at high levels in undifferentiated F9 cells and decreases during differentiation of F9 cells. SOX17 induction is consistent with previous studies of the differentiation of F9 cells (6) . The antibody to SOX17 recognized one primary band of appropriate size in differentiated F9 nuclear extract.
We performed immunocytochemistry to determine the percentage of cells expressing SOX17 after 4 days of endoderm differentiation. Immunocytochemistry showed SOX17 staining in the nucleus of differentiated F9 cells consistent with the role of SOX17 as a transcription factor (Fig. 1B) . The percentage of SOX17-positive cells at day 4 of differentiation was between 50% and 80% of cells in four independent experiments.
Identification of SOX17 targets with ChIP cloning. We prepared chromatin from differentiated F9 cells and used it for ChIP with a SOX17 antibody (SOX17-ChIP), IgG control (IgG-ChIP), or no antibody (NoAb-ChIP) to test for the specificity of SOX17-ChIP. In initial experiments, primers flanking the known SOX17 binding sites in the Lama1 enhancer (24) were used as a positive control and primers flanking the transcriptional start site of the Cps1 promoter, which is not known to be regulated by SOX17, were used as a negative control. Lama1 enhancer DNA was amplified from SOX17-ChIP samples but was not present in NoAb-ChIP or IgG-ChIP (Fig. 1D) . In addition, Cps1 promoter was amplified in total input samples (data not shown) but only minimally in SOX17-ChIP, IgG-ChIP, or NoAb-ChIP (Fig. 1D ). This demonstrated a high level of specificity for SOX17-ChIP, which is necessary for ChIP-cloning. On confirming the specificity of SOX17-ChIP, we repeated the ChIP and pooled the eluates to use for cloning.
We used PCR to amplify the insert DNA from 509 clones and sent 158 clones for sequencing. From these 158 sequenced clones, we found that 43 corresponded to mouse genomic sequence. There were 10 duplicate sequences, and 3 could not be mapped to a specific location in the mouse genome. This resulted in a final 30 unique mouse clones. Of these 30 clones, 14 were highly repetitive (contained Ͼ80% repeat sequence), and we focused on the remaining 16 clones. To determine whether these sequences were pulled down specifically, we designed PCR primers to flank the putative SOX17 binding sites. We used independent ChIPs as templates for PCR. Enrichment values (SOX17-ChIP/IgGChIP) were determined by densitometric analysis and were ϳ15-fold for all clones tested, suggesting that the cloned DNA fragments are indeed bound by SOX17 in differentiated F9 cells and are not a result of cloning nonspecific DNA (Fig. 2) . We then associated SOX17-ChIP clones with a gene by using the BLAT (16) program at http:// genome.ucsc.edu and identifying the nearest RefSeq gene, or mRNA that had supporting EST data ( Table 1) .
Expression of Sox17 and Zfp202. We assayed the expression of the 29 genes associated with the ChIP DNA fragments in both SOX17-negative undifferentiated F9 cells (uF9) and SOX17-positive differentiated F9 cells (dF9) ( Table 1) . Twenty-one genes were expressed during F9 differentiation, and 13 of these were induced Ͼ1.5-fold. Expression levels for five genes decreased Ͼ1.5-fold (dF9/uF9 Ͻ 0.67), and three showed no change in expression during differentiation. Zfp202 (zinc finger protein 202), associated with clone P6G2, was detected in undifferentiated F9 cells and was upregulated 2.8-fold during F9 differentiation (Table 1) .
SOX17 binds to clone P6G2 in EMSA.
After confirming enrichment of the cloned DNA fragments in independent ChIPs, we performed EMSA for selected clones to identify functional SOX17 sites. Putative SOX17 binding sites were selected by using ESPSearch (42) with the consensus site (A/G)ACAA(A/T) derived from published SOX17 binding sites (15, 23, 24, 34) . We focused on clone P6G2, which is located in the first intron of Zfp202 and has two putative SOX17 binding sites separated by 20 bp: GACAAT (site A) and GACAAA (site B) on the opposite strand (Fig. 3A) . We designed separate 36-mer oligos to both of these sites that included the putative site and 15 bp of flanking sequence on either side. EMSA was performed with in vitro transcribed/ translated (ivt) SOX17 protein or TnT extract only (lane 1). EMSA clearly demonstrates a shift for site A, which is due to SOX17 (lane 2), but not for site B (Fig. 3, B and C) . In addition, the shift from SOX17 is effectively competed away by addition of excess wild-type unlabeled probe (lane 3), but not when excess mutant unlabeled probe was added, indicating a site-specific shift due to SOX17 (lane 4).
Full transcriptional activity of clone P6G2 is dependent on SOX17. We cloned P6G2 into pGL3-MP (P6G2ϩ and P6G2Ϫ constructs) in both orientations to assess its transcriptional effect. We transfected these constructs into differentiated F9 cells and assayed for luciferase activity after 24 h. Transcriptional enhancement relative to pGL3-MP (minimal promoter construct) was seen when the P6G2ϩ construct was transfected into differentiated F9 cells, but not when P6G2Ϫ was transfected, suggesting that it may act as an alternative promoter (Fig. 4) . This is supported by its location within intron 1 but upstream of the ATG start codon in exon 2.
To assess whether the putative SOX17 sites were responsible for the enhancing effect of P6G2 we mutated the core sequence (CAA) within the SOX17 binding sites, which is essential for many Sox binding sites (20) . Mutated vectors were transfected into differentiated F9 cells. Mutation of site A within P6G2 caused a decrease in expression of luciferase of ϳ60% in the positive orientation (P ϭ 0.0027, Fig. 4 ), while mutation of site B did not affect expression (Fig. 4) . This is consistent with EMSA analysis demonstrating SOX17 binding to site A but not to site B. When sites A and B were mutated in combination, expression also decreased (P ϭ 0.0033, Fig. 4 ).
Zfp202 and Sox17 colocalize during embryogenesis. We next asked whether Zfp202 and Sox17 expression colocalize during embryogenesis. We performed whole mount in situ hybridization for Sox17 and Zfp202 on E7.75 mouse embryos. By E7.75, Sox17 expression is limited to the anterior definitive endoderm with a punctate staining pattern. Our in situ hybridizations for Sox17 are consistent with this pattern and also demonstrate staining in the foregut diverticulum and allantois (Fig. 5, D-F) .
A probe designed to the 3Ј-UTR of Zfp202 was used for whole mount in situ hybridization. Zfp202 staining was only found in the anterior and posterior third of the E7.75 embryo. Zfp202 staining was seen in the neural folds as well as the foregut diverticulum and allantois (Fig. 5, A-C) .
ZFP202 represses transcription from the Hnf4a promoter. The literature revealed no publications on Zfp202; however, the human ortholog of Zfp202, ZNF202, was reported to repress hepatocyte nuclear factor 4␣ (HNF4A) (41) . Given that Sox17 and Zfp202 were both expressed in the anterior definitive endoderm just prior to Hnf4a expression, we tested whether ZFP202 could repress transcription from the Hnf4a promoter. We compared the activity of the mouse Hnf4a promoter in HepG2 cells with or without addition of a constitutive Zfp202 construct. Transcriptional activity was reduced ϳ40% in the presence of Zfp202 (P ϭ 0.039, Fig. 6 ).
DISCUSSION
Here we have identified direct targets of SOX17 during in vitro endoderm differentiation. In particular, SOX17 binds to a site in the first intron of Zfp202 and activates transcription. We demonstrated that this sequence is specifically immunoprecipitated in independent ChIPs. Zfp202 expression is induced concomitantly with Sox17 during endoderm differentiation from F9 cells and colocalizes with Sox17 in embryos, suggesting that Zfp202 is regulated by SOX17. We further showed that SOX17 binds one of two putative SOX17 binding sites within clone P6G2 in EMSAs. Luciferase assays using this sequence demonstrate the orientation-dependent regulatory activity of clone P6G2. Furthermore, mutation of SOX17 site A decreases this enhancing activity by 60%. Zfp202 and Sox17 are coexpressed during murine embryogenesis in the anterior foregut and the allantois. Zfp202 is directly regulated by SOX17 through a binding site within the first intron of Zfp202 during mammalian endoderm differentiation in vitro.
Since P6G2 is located upstream of the ATG start codon and its enhancing activity is orientation dependent, it is possible that this sequence serves as an alternative promoter for Zfp202. The regulation of Zfp202 and its downstream target genes is largely unknown, but its human ortholog ZNF202 has been characterized. ZNF202 has been reported to have 6 (22) or 10 (33, 41) exons. Analysis of EST data suggests that most ZNF202 transcripts contain seven exons corresponding to the seven exons of Zfp202, while two ESTs contain two additional upstream exons.
ZNF202 is a transcriptional repressor and functions in the regulation of HDL metabolism (18, 30, 33, 41) . The positive regulation of Zfp202 by SOX17 suggests that SOX17 may have indirect suppressive effects on genes of HDL metabolism. HNF4A has been shown to be a direct target of ZNF202 (41) . We have shown that ZFP202 represses the activity of the murine Hnf4a promoter.
It is possible that SOX17 activation of Zfp202 and ZFP202 repression of Hnf4a is a mechanism to establish timing of hepatogenesis in embryos. Hnf4a expression is initiated in the anterior definitive endoderm shortly after Sox17 expression wanes (5, 14, 39 ). Zfp202 contains a PEST domain and therefore is rapidly degraded. This allows for a scenario in which SOX17 indirectly represses Hnf4a expression through ZFP202 activity and prevents hepatocyte differentiation until gastrulation is complete. Hnf4a is critical to hepatocyte differentiation and morphogenesis (27) . The indirect repression of Hnf4a by Sox17 may be part of a mechanism involved in the timing of endodermal organogenesis. Interestingly, in the visceral endoderm, both Sox17 and Hnf4a are expressed (5, 14, 39) but Zfp202 is not detected by in situ hybridization. It is likely that ZFP202 has as yet unidentified targets that may better explain its regulation by SOX17 in early embryos.
We have demonstrated the utility of an unbiased approach to the identification of SOX17 regulatory sequences during mammalian endoderm differentiation. We have analyzed a sequence in the first intron of Zfp202 in detail. Further analysis of additional SOX17 target sequences and associated genes may provide a better understanding of the molecular events underlying endoderm formation and differentiation.
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